Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mupirocin for Nasal S. aureus Colonization in HHT
NCT02963129Phase 3Unknown
- Sponsor
- Hospital Italiano de Buenos Aires
- Start
- Jun 2017
- Primary completion
- Jun 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mupirocin in hereditary hemorrhagic telangiectasia (HHT), sponsored by Hospital Italiano de Buenos Aires. Status: unknown.
02
Drugs
mupirocin
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT02963129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02963129.